indomethacin and Brachial Paresis

indomethacin has been researched along with Brachial Paresis in 1 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Research

Studies (1)

Authors

Clinical Trials (1)

Trial Overview

Trial Outcomes

Assess the Acute and Late Toxicity of Spinal Radiosurgery

CTCAE version 3. Acute toxicity will be recorded if toxicity occurs early phase or within 3 months, and late toxicity would be any toxicity that follows those 3 months. (NCT00573872)
Timeframe: 2 years

Number of Participants With Lack of Tumor Growth at Last Follow-up

Lack of tumor growth by CT or MRI at last follow-up (NCT00573872)
Timeframe: 2 years

Number of Participants With Palliative Response (Pain or Relief of Neurologic Symptoms) From Single Fraction Radiosurgery Delivered With Tomotherapy

"Physician's subjective report of palliative pain relief. The maximal benefit patient received (best response) is reported. Scale is pain described as worse, stable, better, or completely resolved. In the reporting better or completely resolved indicates response to treatment." (NCT00573872)
Timeframe: 2 years

Other Studies

1 other study available for indomethacin and Brachial Paresis